Answer
Tablet and oral-suspension formulations are not bioequivalent. Any change must be arranged by the specialist team using formulation-specific prescribing.
Sources for this answer
- Dasatinib 50 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 1